Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors

BackgroundInfluenza vaccination (FV) is recommended for patients with cancer. Recent data suggested that the administration of the FV was associated with an increase in immune-related adverse events (irAEs) among patients on immune checkpoint inhibitors (ICIs). Myocarditis is an uncommon but serious...

Full description

Bibliographic Details
Main Authors: Justine V. Cohen, Doll Lauren Alexandra Golden, Syed S. Mahmood, Raza M. Alvi, Nathaniel D. Mercaldo, Malek Z. O. Hassan, Adam Rokicki, Connor Mulligan, Sean P. T. Murphy, Maeve Jones-O’Connor, Lucie M. Heinzerling, Rongras Damrongwatanasuk, Carol L. Chen, Michael C. Kirchberger, Sachin P. Shah, Muhammad A. Rizvi, Carlo G. Tocchetti, Valentina Mercurio, Donald P. Lawrence, John D. Groarke, Michael G. Fradley, Kerry L. Reynolds, Tomas G. Neilan
Format: Article
Language:English
Published: BMJ Publishing Group 2019-03-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/7/1/53.full

Internet

https://jitc.bmj.com/content/7/1/53.full

Similar Items